BD granted FDA clearance for sample preparation system

By The Science Advisory Board staff writers

October 6, 2020 -- Becton Dickinson (BD) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an integrated sample preparation system, FacsDuet.

The BD FacsLyric Flow Cytometer with BD FacsDuet sample preparation system allows facilities to fully automate the assay sample process. The automated system helps speed up time to an answer and reduces errors by limiting manual user interactions, according to the company.

The system integrates with existing BD flow cytometry solutions. It also works with the BD FacsLink middleware solution for bidirectional communication of data between instruments and laboratory information systems.

Life science instrumentation market adapts to COVID-19
To reflect the new realities of the analytical instrumentation market during the COVID-19 pandemic and in the subsequent pandemic-driven recession, Strategic...
BD to provide injection devices for mass doses of COVID-19 vaccines
Becton Dickinson (BD) formed a strategic partnership with the Biomedical Advanced Research and Development Authority to develop new manufacturing lines...
High-throughput analysis speeds downstream process development
Adding high-throughput analysis helped speed up downstream process development for drug candidates based on monoclonal antibodies, according to a case...
BD revenues edge up for 2nd quarter
Becton Dickinson (BD) saw its revenues grow slightly for the second quarter, but the company withdrew its previously issued guidance due to fallout from...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter